Hugo Calderón
- Oncology top 10%
- Molecular Biology
- Genetics top 10%
- Immunology
- Biomedical Engineering
- Co-authors
- Sònia GuedanMarcela V. MausAvery D. PoseyRamón AlemanyA. RajanJerome CustersNaresh ChandraDragomira Majhen
- Topics
- CAR-T cell therapy research (10 papers)Virus-based gene therapy research (6 papers)RNA Interference and Gene Delivery (3 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Hugo Calderón
9 papers receiving 515 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 388
- Molecular Biology 199
- Genetics 197
- Immunology 179
- Biomedical Engineering 103
Countries citing papers authored by Hugo Calderón
This map shows the geographic impact of Hugo Calderón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Calderón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Calderón more than expected).
Fields of papers citing papers by Hugo Calderón
This network shows the impact of papers produced by Hugo Calderón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Calderón. The network helps show where Hugo Calderón may publish in the future.
Co-authorship network of co-authors of Hugo Calderón
This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Calderón. A scholar is included among the top collaborators of Hugo Calderón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Calderón. Hugo Calderón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 23 | |
| 6 | 9 | |
| 7 | 0 | |
| 8 | Engineering and Design of Chimeric Antigen Receptorsbreakdown → | 325 |
| 9 | 24 | |
| 10 | 43 | |
| 11 | 11 | |
| 12 | Evaluation of Enadenotucirev (ColoAd1), an oncolytic Ad11/Ad3 chimeric group B adenovirus, in combination with chemotherapeutic agents in a murine model of ovarian cancer | 1 |
| 13 | 82 |
About Hugo Calderón
Hugo Calderón is a scholar working on Oncology, Biotechnology and Genetics, having authored 13 papers that have together received 524 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (6 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Oncology (388 citations), Immunology (179 citations) and Genetics (197 citations). Hugo Calderón has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Sònia Guedan, Marcela V. Maus, Avery D. Posey, Ramón Alemany, A. Rajan, Jerome Custers, Naresh Chandra, Dragomira Majhen, Carlos Alberto Fajardo and Brian Champion. Their work appears in journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.